Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of hydroxychloroquine in treating
patients with solid tumors undergoing radiation therapy for bone metastases. Drugs, such as
hydroxychloroquine, may make tumor cells more sensitive to radiation therapy